Plasmapheresis in Immunologic Renal Disease
نویسندگان
چکیده
منابع مشابه
Plasmapheresis in immunologic renal disease.
Plasmapheresis has been used in the management of immunologic renal disease for the last 40 years. The rationale behind this approach is to remove pathogenic immune mediators, such as autoantibodies and immune complexes, from the circulation. There may also be benefit in depleting proinflammatory molecules, such as complement components and coagulation factors. Initial experience was gained in ...
متن کاملTherapeutic plasmapheresis in patients with renal disease.
Therapeutic plasmapheresis has been enthusiastically applied in recent years to a number of disease entities associated with renal failure. It seems reasonable to attempt removal of intravascular macroglobulins or immune complexes by this mechanism; however, multiple modalities of therapy are often employed virtually simultaneously, confounding the delineation of successful treatment. Two case ...
متن کاملPlasmapheresis in Raynaud's disease.
Understanding of the pathogenesis, clinical course, and treatment of Raynaud's disease is confused and unsatisfactory, and no success in treatment can be promised. Five patients with severe Raynaud's disease, who had not responded to other forms of treatment, were treated by plasmapheresis, which produced a striking improvement. Ultrasonic velocimetry showed that segments of digital arteries wh...
متن کاملImmunologic Factors in Acute Rheumatic Fever Compared to Rheumatic Heart Disease
Background/Objective: To clarify the state of different immunologic factors in patients with acute rheumatic fever (ARF) and rheumatic heart disease (RHD) compared to healthy individuals.Patients and Methods: Patients with ARF (#21), patients with RHD six months after the onset of ARF (#19), and healthy children from the same age group with normal physical examination and no history of pharyngi...
متن کاملPartial immunologic reconstitution of a patient with acquired agammaglobulinemia: a transient phenomenon accompanying therapeutic plasmapheresis.
A patient with acquired agammaglobulinemia was treated with plasmapheresis. The rationale for this procedure was based on the presence of a cytotoxic autoantibody with specificity for helper (TH2-) T lymphocytes. Plasmapheresis reduced the autoantibody concentration to undetectable levels, which resulted in an increase number of helper T cells. These T cells provided normal in vitro helper acti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood Purification
سال: 2012
ISSN: 1421-9735,0253-5068
DOI: 10.1159/000334155